Editors' Picks
Pfizer’s BRAFTOVI Boosts Tumor Response to 64.4% in Aggressive Colorectal Cancer Patients
2026-01-14
2026 Cardiometabolic and Weight-Loss Watchlist: Trials That Could Mint the Next Trillion-Dollar Giant
2026-01-14
AbbVie Bets $5.6 Billion on PD-1×VEGF Bispecifics, Licensing RemeGen’s RC148 to Expand Its Oncology Arsenal
2026-01-13
Japan’s Eisai and U.S.-Based Nuvation Bio Secure Europe, Middle East Rights for Lung Cancer Drug in €195M Deal
2026-01-13
JP Morgan 2026: Eight Companies’ Clinical Milestones across tRNA Medicines, Immune Reset, and Oncology
2026-01-13
From Pipeline to Payday: The Rare Disease Assets Most Likely to Spark a 2026 M&A Land-Grab
2026-01-13
Resilience Over Expansion: What J.P. Morgan’s 2026 Outlook Reveals About Business Strategy Amid Macro Uncertainty
2026-01-08
LATEST
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
EVENT
2026-04-09
4th Cell & Gene Therapy Innovation & Access Congress: Asia (Media Partnership)
Seoul, South Korea



